INmune Bio, Inc. (INMB) Tops Q2 EPS by 4c
INmune Bio, Inc. (NASDAQ: INMB) reported Q2 EPS of ($0.36), $0.04 better than the analyst estimate of ($0.40).
For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.
INmune Bio, Inc. (NASDAQ: INMB) reported Q2 EPS of ($0.36), $0.04 better than the analyst estimate of ($0.40).
For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.